The wire › SEC Form 8-K
Estrella Immunopharma, Inc. ESLA
Filed with the SEC on May 2, 2025. Reported event date Apr 30, 2025.
- Business address
- Emeryville, CA
- State
- California
- Incorporated in
- not given
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 1844417
- Accession number
- 0001213900-25-039261
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing